Implementing a New Method for Activated Clotting Time:
Authors:
- John G. ToffalettiJTJohn G. Toffaletti
- Elizabeth H. McDonnellEMElizabeth H. McDonnell
- Ian WelsbyIWIan Welsby
- Ian R. ShearerISIan R. Shearer
- Michael H. SketchMSMichael H. Sketch
- James E. TchengJTJames E. Tcheng
- 1 June 2003
- journal article
- Published by Wolters Kluwer Health in Point of Care: The Journal of Near-Patient Testing & Technology
- Vol. 2 (2) , 125-128
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACTThrombosis and Haemostasis, 1996
- Monitoring of Heparin-induced Anticoagulation with Kaolinactivated Clotting Time in Cardiac Surgical Patients Treated with AprotininAnesthesiology, 1992
- Adequate heparinization during PTCA: Assessment using activated clotting timesCatheterization and Cardiovascular Diagnosis, 1989
- Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1980
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Activated coagulation time of whole bloodJAMA, 1966